- Report
- January 2024
- 200 Pages
Global
From €3986EUR$4,150USD£3,432GBP
- Report
- February 2021
- 360 Pages
United States
From €2305EUR$2,400USD£1,985GBP
- Report
- June 2019
- 14 Pages
Global
€9605EUR$10,000USD£8,269GBP
- Report
- January 2019
- 717 Pages
Global
From €21130EUR$22,000USD£18,192GBP
- Report
- November 2023
- 35 Pages
Global
From €3544EUR$3,690USD£3,051GBP
Epivir is a brand name for the antiretroviral drug lamivudine, which is used to treat HIV/AIDS. It is a nucleoside reverse transcriptase inhibitor (NRTI) that works by blocking the action of the enzyme reverse transcriptase, which is necessary for the virus to replicate. Epivir is usually prescribed in combination with other antiretroviral drugs to treat HIV infection. It is available in tablet, oral solution, and injection forms.
Epivir is used to reduce the amount of HIV in the body and to prevent the virus from multiplying. It is also used to reduce the risk of HIV transmission from mother to child during pregnancy and delivery. Epivir is generally well tolerated, but side effects may include nausea, vomiting, headache, and diarrhea.
Epivir is manufactured by several companies, including GlaxoSmithKline, Bristol-Myers Squibb, and Teva Pharmaceuticals. It is available in many countries around the world, including the United States, Canada, and the United Kingdom. Show Less Read more